[BKAWAN] YoY Annualized Quarter Result on 31-Mar-2010 [#2]

Stock
[BKAWAN] BATU KAWAN BHD
Announcement Date
26-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2010
Quarter
31-Mar-2010 [#2]
Profit Trend
QoQ- -5.87%
YoY- 68.76%
Quarter Report
Latest QR
Upcoming QR
BKAWAN's Result
BKAWAN's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 9,414,702 334,668 271,892 223,678 240,950 232,120 223,628 86.40%
PBT 1,357,892 581,822 682,986 443,464 281,500 524,394 299,860 28.59%
Tax -297,046 -15,794 -12,472 -5,462 -14,264 -8,380 -4,886 98.17%
NP 1,060,846 566,028 670,514 438,002 267,236 516,014 294,974 23.75%
-
NP to SH 495,622 560,490 665,938 436,248 258,502 509,312 287,352 9.50%
-
Tax Rate 21.88% 2.71% 1.83% 1.23% 5.07% 1.60% 1.63% -
Total Cost 8,353,856 -231,360 -398,622 -214,324 -26,286 -283,894 -71,346 -
-
Net Worth 3,810,878 3,668,237 3,310,854 3,007,286 2,708,725 2,643,308 2,385,203 8.11%
Dividend
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Div 124,674 125,053 125,569 127,607 85,314 129,573 86,734 6.22%
Div Payout % 25.16% 22.31% 18.86% 29.25% 33.00% 25.44% 30.18% -
Equity
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Net Worth 3,810,878 3,668,237 3,310,854 3,007,286 2,708,725 2,643,308 2,385,203 8.11%
NOSH 415,581 416,845 418,565 425,358 426,570 431,913 433,673 -0.70%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin 11.27% 169.13% 246.61% 195.82% 110.91% 222.30% 131.90% -
ROE 13.01% 15.28% 20.11% 14.51% 9.54% 19.27% 12.05% -
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 2,265.43 80.29 64.96 52.59 56.49 53.74 51.57 87.73%
EPS 119.26 134.46 159.10 102.56 60.60 117.92 66.26 10.28%
DPS 30.00 30.00 30.00 30.00 20.00 30.00 20.00 6.98%
NAPS 9.17 8.80 7.91 7.07 6.35 6.12 5.50 8.88%
Adjusted Per Share Value based on latest NOSH - 425,374
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 2,122.03 75.43 61.28 50.42 54.31 52.32 50.40 86.41%
EPS 111.71 126.33 150.10 98.33 58.27 114.80 64.77 9.50%
DPS 28.10 28.19 28.30 28.76 19.23 29.21 19.55 6.22%
NAPS 8.5895 8.268 7.4625 6.7783 6.1053 5.9579 5.3761 8.11%
Price Multiplier on Financial Quarter End Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 -
Price 18.10 18.68 15.24 10.68 8.00 10.10 8.25 -
P/RPS 0.80 23.27 23.46 20.31 14.16 18.79 16.00 -39.27%
P/EPS 15.18 13.89 9.58 10.41 13.20 8.57 12.45 3.35%
EY 6.59 7.20 10.44 9.60 7.58 11.68 8.03 -3.23%
DY 1.66 1.61 1.97 2.81 2.50 2.97 2.42 -6.08%
P/NAPS 1.97 2.12 1.93 1.51 1.26 1.65 1.50 4.64%
Price Multiplier on Announcement Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 22/05/13 24/05/12 25/05/11 26/05/10 27/05/09 21/05/08 23/05/07 -
Price 19.10 17.90 16.22 10.40 8.80 11.30 9.10 -
P/RPS 0.84 22.30 24.97 19.78 15.58 21.03 17.65 -39.77%
P/EPS 16.02 13.31 10.19 10.14 14.52 9.58 13.73 2.60%
EY 6.24 7.51 9.81 9.86 6.89 10.44 7.28 -2.53%
DY 1.57 1.68 1.85 2.88 2.27 2.65 2.20 -5.46%
P/NAPS 2.08 2.03 2.05 1.47 1.39 1.85 1.65 3.93%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment